Drug intelligence / Profile preview

MAO-A siRNA

Development stage
Preclinical
Lead developer
Mayo Clinic
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

MAO-A siRNA is a small interfering RNA designed to silence the expression of Monoamine Oxidase-A (MAO-A), a mitochondrial enzyme involved in the degradation of monoamine neurotransmitters and the generation of reactive oxygen species (ROS). In preclinical research, specifically in models of heart failure with preserved ejection fraction (HFpEF), MAO-A siRNA has been used to demonstrate that MAO-A promotes cardiomyocyte senescence and diastolic dysfunction through the cGAS-STING signaling pathway. By reducing MAO-A levels, the siRNA attenuates mitochondrial ROS production, mtDNA leakage, and the subsequent activation of inflammatory and senescence-associated secretory phenotypes (SASP).

Other names
Monoamine oxidase-A siRNAMAO-A silencing RNA
02

Targets

AGO2 (Argonaute RISC catalytic component 2)MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on MAO-A siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAO-A siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call